112 related articles for article (PubMed ID: 8121308)
21. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
22. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
23. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
24. Uptake of cholesterol from the very low density lipoprotein or its remnants by the perfused rat liver.
Noël SP; Rubinstein D
Can J Biochem; 1981 Jun; 59(6):447-53. PubMed ID: 6945896
[TBL] [Abstract][Full Text] [Related]
25. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans.
Kasim-Karakas SE; Herrmann R; Almario R
Metabolism; 1995 Sep; 44(9):1223-30. PubMed ID: 7666799
[TBL] [Abstract][Full Text] [Related]
26. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of triglyceride-rich nascent rat hepatic high density lipoproteins.
Winkler KE; Marsh JB
J Lipid Res; 1989 Jul; 30(7):989-96. PubMed ID: 2794797
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.
Goldberg IJ; Le NA; Ginsberg HN; Krauss RM; Lindgren FT
J Clin Invest; 1988 Feb; 81(2):561-8. PubMed ID: 3276735
[TBL] [Abstract][Full Text] [Related]
29. Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism.
Mamo JC; Hirano T; James L; Szeto L; Steiner G
Metabolism; 1991 Sep; 40(9):888-93. PubMed ID: 1895953
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey.
Goldberg IJ; Le NA; Paterniti JR; Ginsberg HN; Lindgren FT; Brown WV
J Clin Invest; 1982 Dec; 70(6):1184-92. PubMed ID: 7174789
[TBL] [Abstract][Full Text] [Related]
33. The effect of cyclosporine and methylprednisolone on plasma lipoprotein levels in rats.
Espino A; Lopez-Miranda J; Blanco-Cerrada J; Zambrana JL; Aumente MA; Paniagua JA; Blanco-Molina A; Jimenez-Pereperez JA; Rodriguez M; Pérez-Jiméz F
J Lab Clin Med; 1995 Feb; 125(2):222-7. PubMed ID: 7844470
[TBL] [Abstract][Full Text] [Related]
34. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
35. Influence of probucol on cholesterol and lipoprotein metabolism in man.
Kesäniemi YA; Grundy SM
J Lipid Res; 1984 Aug; 25(8):780-90. PubMed ID: 6491523
[TBL] [Abstract][Full Text] [Related]
36. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat.
Bagdade JD; Yee E; Albers J; Pykalisto OJ
Metabolism; 1976 May; 25(5):533-42. PubMed ID: 177840
[TBL] [Abstract][Full Text] [Related]
38. Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits.
Ying H; Saku K; Harada R; Takami N; Sasaki N; Saito Y; Arakawa K
Biochim Biophys Acta; 1990 Dec; 1047(3):247-54. PubMed ID: 2123720
[TBL] [Abstract][Full Text] [Related]
39. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Staels B; Van Tol A; Fruchart JC; Auwerx J
Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
[TBL] [Abstract][Full Text] [Related]
40. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis.
Marsh JB; Sparks CE
J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
